Novavax
NVAX
#5751
Rank
HK$8.74 B
Marketcap
HK$53.79
Share price
0.73%
Change (1 day)
-16.72%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of September 2025 : HK$1.95 Billion

According to Novavax's latest financial reports the company's total debt is HK$1.95 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$1.78 B-0.02%
2023-12-31HK$1.78 B-58.35%
2022-12-31HK$4.29 B21.34%
2021-12-31HK$3.54 B-2.42%
2020-12-31HK$3.62 B44.72%
2019-12-31HK$2.50 B0.29%
2018-12-31HK$2.49 B0.68%
2017-12-31HK$2.48 B1.21%
2016-12-31HK$2.45 B80025.5%
2015-12-31HK$3.06 M-60.45%
2014-12-31HK$7.74 M-46.93%
2013-12-31HK$14.58 M56.16%
2012-12-31HK$9.34 M275.8%
2011-12-31HK$2.48 M-20.16%
2010-12-31HK$3.11 M-17.39%
2009-12-31HK$3.76 M-97.87%
2008-12-31HK$0.17 B-0.2%
2007-12-31HK$0.17 B-1.65%
2006-12-31HK$0.18 B-23.81%
2005-12-31HK$0.23 B-18.04%
2004-12-31HK$0.28 B-11.63%
2003-12-31HK$0.32 B1.22%
2002-12-31HK$0.32 B20.6%
2001-12-31HK$0.26 B71.65%
2000-12-31HK$0.15 B19978.55%
1999-12-31HK$0.77 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
HK$0.35 B-81.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$9.73 B 397.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$5.16 B 164.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$5.02 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$254.02 B 12,893.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$473.66 B 24,128.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$249.27 B 12,650.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
HK$11.67 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$185.75 B 9,401.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
HK$20.4 M-98.96%๐Ÿ‡บ๐Ÿ‡ธ USA